Going Global - MTPConnect National » MTPConnect National

Promoting engagement with international markets and access to global supply chains.

To be successful, Australian life science companies need to develop their products for global markets. International connections are critical to understanding market opportunities and the development, regulatory and reimbursement requirements needed to enter these markets. MTPConnect has developed programs to support international conference delegations, site visits and activities to help you and your company access international markets and global supply chains.

Australia’s innovative life sciences sector on show at BIO 2025

San Diego US, 22 – 25 June 2026

The premier business partnering biotechnology conference in the world attracted close to 20,000 registrants last year with over 500 Australian delegates in attendance. Plan to be in San Diego 18 June 2026 for MTPConnect’s popular two-day visit program to world leading biotech companies and facilities and make invaluable connections with leaders in the sector.

We will also be hosting several unique events including our American Australian Association-MTPConnect BIO 2026 Dinner (21 June) and the celebrated Women in Life Sciences Leadership Breakfast (23 June).

Register your interest to attend BIO with your State Trade Agency:

NSW – Hanh Hoang
QLD – Sarah Roberts
VIC – Libby Kruse
WA – Clare Goodall
SA – Sandra Hack

The MedTech Conference (AdvaMed)

Boston US, 18-21 October 2026

We have been taking organisations to The Medtech Conference since 2017. It is an opportunity to help open-up new US market, commercial and collaboration opportunities for Australia’s emerging medtech start-ups and SMEs.

For emerging medtech companies, universities, research institutes and service companies, The MedTech Conference delivers world-class speakers, a cross-cutting educational program, invaluable networking (with investors, strategics and potential partners) and next-level technology, and this forum for transformational ideas is a can’t-miss event for the industry’s prominent and most promising companies. As well as connecting and showcasing Australia’s promising medtech start-ups, our focus for 2026 will be promoting the “Australian Advantage” for medical device product development and clinical trials.

MTPConnect will organise a valuable two-day site visit program on 15-16 October 2026, ahead of the MedTech Conference, so plan to be in Boston early.

Bio Korea

Seoul, 29 April – 1 May 2026

Korea is Australia’s fourth largest two-way trading partner and is an emerging leader in life sciences. MTPConnect has an MoU with the Korean Government (through Korean Health Industry Development Institute) and is working to expand cooperation and opportunities for Australian companies. In 2025, we supported Austrade and State Trade Agencies to showcase Australia’s biotech capabilities at the conference.

Register your interest to attend with your State Trade Agency:

NSW – Hanh Hoang
QLD – Sarah Roberts
VIC – Libby Kruse
WA – Clare Goodall
SA – Sandra Hack

Bio Asia-Taiwan Conference

Taipei, 16-19 July 2026

Jointly organised by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO), the BIO Asia–Taiwan International Conference and Exhibition was held for the first time in 2019. This annual gathering recognises Asia as a region of growing importance within the industry and celebrates Taiwan’s standing as a leading biotechnology hub.

Register your interest to attend with Austrade Taiwan

Contact Duli Chang – Senior Business Development Manager, Austrade Taiwan

Global Health Expo Saudi Arabia

MTPConnect’s inaugural life sciences delegation to Saudi Arabia for the Global Health Exhibition took place from 26–30 October 2025.The trade mission was to attend the GHE25 exhibition at the Riyadh Exhibition and Convention Centre and included a series of curated meetings and site visits.

Why Saudi Arabia?

Saudi Arabia’s healthcare sector is undergoing a significant transformation as it emerges as a global hub for innovation, investment and digital health. Under Vision 2030, the Kingdom is investing heavily in building a patient-centred, tech-enabled health system — creating new opportunities for global collaboration and partnerships.

Saudi Arabia recently published it’s National Biotechnology Strategy to position Saudi Arabia as a regional and global biotech hub with a far-reaching impact in biomanufacturing and medical innovation.

Underscoring Saudi Arabia’s level of interest in Australia’s ecosystem, this week saw a visit from Saudi Minister of Health, Fahad Al-Jalajel to Melbourne, Canberra and Sydney to enhance bilateral cooperation in healthcare innovation and investment.

This mission offers a rare opportunity to access one of the world’s fastest-growing healthcare markets.

Opportunities in the Saudi Market:

Precision Medicine and Biotech: Strong interest in genomic screening, personalised therapies, and cutting-edge biotech research.
Biomanufacturing including Vaccine manufacturing
Digital Health and AI: High demand for remote monitoring, telehealth, AI diagnostics, and data-driven patient care tools.
Clinical Trials: Saudi Arabia has a large focus on clinical trials and will imminently release it’s blueprint for this sector.
Value-Based Care: Saudi Arabia is shifting towards outcome-focused healthcare, opening the door for companies with data solutions and value-based business models.
Public-Private Partnerships: Major reforms are creating opportunities for private sector involvement in infrastructure, service delivery, and innovation.
Health Financing and Insurance: Market reform and privatisation are driving innovation in health insurance and sustainable financing models.

BIO Middle East

Riyadh, Saudi Arabia, 14-16 December 2026

A new era of biotechnology innovation is dawning in the Middle East. Mark your calendars for 14-16 December 2026 as BIO Middle East, the region’s premier biotechnology and life sciences event, launches in the thriving heart of Riyadh.

Co-located with CPHI Middle East, this inaugural event is more than a conference; it’s a pivotal gathering bringing together global and regional leaders, innovators, and investors to collectively shape the future of the rapidly evolving pharma and biotech sectors.

BIO Middle East is strategically positioned as the central platform for unprecedented collaboration, vital investment, and crucial knowledge exchange. With the ambitious goals of Saudi Arabia’s Vision 2030 and the National Biotechnology Strategy, a powerful synergy is propelling the Kingdom and the wider region, to the forefront of the global biotech landscape, with a laser focus on high-growth areas.

Stay tuned for MTPConnect’s plans for a trade mission to the inaugural BIO Middle East conference.

ANDHealth Delegations

ANDHealth Delegation to US
San Francisco & Las Vegas US, 11 – 18 November 2026

Australia’s leading provider of commercialisation support and services to the fast-growing digital and connected health sector, ANDHealth, has led the Australian delegation to HLTH USA Conference, digital health’s vanguard event for a number of years. Over 7,500 registrants to HLTH make this a must-attend opportunity for digital health companies. ANDHealth delivers a full program to support Australian companies, with more details here and to follow.

ANDHealth Delegation to UK & EU Markets
8 – 18 June 2026

Seeing firsthand the transformative impact global conferences can have for companies looking to expand into new markets, the most effective way to truly understand international markets is to experience them on the ground. Join ANDHealth for their proven framework for supporting companies as they enter these international markets.

Key activities:

London Tech Week (8-12 June)
NHS Confed Expo Manchester (10-11 June)
HLTH Europe Amsterdam (15-18 June)

More information here.

Partnerships and Collaborations

Finding new markets and accessing global supply chains is critical for Australian companies to compete internationally, while maintaining their operations in Australia which is why MTPConnect’s focus on international engagement is strong.

MTPConnect has executed partnership agreements with leading life science organisations in the United States and South Korea. The agreements – with Biocom California, Medical Alley, Saudi Ministry of Health and the Korea Health Industry Development Institute (KHIDI)– allow for enhanced cooperation and key connections to build commercial opportunities in priority global markets.